×

DexCom Retained Earnings (Accumulated Deficit) 2010-2024 | DXCM

DexCom retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • DexCom retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $1.446B, a 88.98% increase year-over-year.
  • DexCom retained earnings (accumulated deficit) for 2023 were $1.021B, a 112.84% increase from 2022.
  • DexCom retained earnings (accumulated deficit) for 2022 were $0.48B, a 246% increase from 2021.
  • DexCom retained earnings (accumulated deficit) for 2021 were $0.139B, a 168.63% decline from 2020.
DexCom Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $1,021
2022 $480
2021 $139
2020 $-202
2019 $-696
2018 $-799
2017 $-672
2016 $-621
2015 $-555
2014 $-498
2013 $-475
2012 $-446
2011 $-391
2010 $-346
2009 $-291
DexCom Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $1,446
2024-06-30 $1,311
2024-03-31 $1,168
2023-12-31 $1,021
2023-09-30 $765
2023-06-30 $644
2023-03-31 $529
2022-12-31 $480
2022-09-30 $388
2022-06-30 $287
2022-03-31 $236
2021-12-31 $139
2021-09-30 $-28
2021-06-30 $-99
2021-03-31 $-162
2020-12-31 $-202
2020-09-30 $-557
2020-06-30 $-630
2020-03-31 $-676
2019-12-31 $-696
2019-09-30 $-788
2019-06-30 $-834
2019-03-31 $-824
2018-12-31 $-799
2018-09-30 $-619
2018-06-30 $-666
2018-03-31 $-696
2017-12-31 $-672
2017-09-30 $-662
2017-06-30 $-660
2017-03-31 $-663
2016-12-31 $-621
2016-09-30 $-614
2016-06-30 $-595
2016-03-31 $-575
2015-12-31 $-555
2015-09-30 $-557
2015-06-30 $-514
2015-03-31 $-511
2014-12-31 $-498
2014-09-30 $-499
2014-06-30 $-494
2014-03-31 $-488
2013-12-31 $-475
2013-09-30 $-473
2013-06-30 $-467
2013-03-31 $-457
2012-12-31 $-446
2012-09-30 $-437
2012-06-30 $-420
2012-03-31 $-405
2011-12-31 $-391
2011-09-30 $-379
2011-06-30 $-366
2011-03-31 $-358
2010-12-31 $-346
2010-09-30 $-337
2010-06-30 $-323
2010-03-31 $-311
2009-12-31 $-291
2009-09-30 $-280
2009-06-30 $-266
2009-03-31 $-251
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $30.662B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $199.883B 24.39
Intuitive Surgical (ISRG) United States $186.649B 97.58
Edwards Lifesciences (EW) United States $42.814B 27.19
Alcon (ALC) Switzerland $41.161B 27.54
IQVIA Holdings (IQV) United States $35.414B 19.51
IDEXX Laboratories (IDXX) United States $33.479B 39.43
Waters (WAT) United States $21.866B 32.33
STERIS (STE) Ireland $19.984B 23.01
SONOVA HOLDING (SONVY) Switzerland $19.343B 0.00
Hologic (HOLX) United States $16.281B 17.58
Fresenius Medical Care AG KGaA (FMS) Germany $12.998B 13.34
Sysmex ADR (SSMXY) Japan $11.450B 35.90
Globus Medical (GMED) United States $11.143B 28.22
Penumbra (PEN) United States $9.211B 90.22
Masimo (MASI) United States $9.025B 43.67
Teleflex (TFX) United States $8.316B 13.26
Glaukos (GKOS) United States $8.253B 0.00
Integer Holdings (ITGR) United States $4.433B 25.13
PROCEPT BioRobotics (PRCT) United States $4.340B 0.00
Veracyte (VCYT) United States $3.134B 94.05
Inari Medical (NARI) United States $3.033B 0.00
LivaNova (LIVN) United Kingdom $2.533B 14.62
Tandem Diabetes Care (TNDM) United States $2.354B 0.00
Nihon Kohden (NHNKY) Japan $2.318B 17.61
TransMedics (TMDX) United States $2.232B 70.75
Elekta AB (EKTAY) Sweden $2.095B 18.83
Integra LifeSciences Holdings (IART) United States $1.776B 9.28
RxSight (RXST) United States $1.393B 0.00
Alphatec Holdings (ATEC) United States $1.285B 0.00
Artivion (AORT) United States $1.177B 78.00
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $0.990B 0.00
Paragon 28 (FNA) United States $0.897B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.728B 12.37
AxoGen (AXGN) United States $0.722B 0.00
Mesa Laboratories (MLAB) United States $0.717B 16.90
IRadimed (IRMD) United States $0.696B 37.63
ORTHOFIX MEDICAL INC (OFIX) United States $0.660B 0.00
SiBone (SIBN) United States $0.584B 0.00
OrthoPediatrics (KIDS) United States $0.554B 0.00
Semler Scientific (SMLR) United States $0.506B 26.63
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.490B 0.00
ClearPoint Neuro (CLPT) United States $0.429B 0.00
Tactile Systems Technology (TCMD) United States $0.411B 22.23
Delcath Systems (DCTH) United States $0.403B 0.00
AngioDynamics (ANGO) United States $0.365B 0.00
NeuroPace (NPCE) United States $0.346B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.219B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Anteris Technologies Global (AVR) Australia $0.199B 0.00
Accuray (ARAY) United States $0.196B 0.00
Sight Sciences (SGHT) United States $0.182B 0.00
KORU Medical Systems (KRMD) United States $0.178B 0.00
Nevro (NVRO) United States $0.139B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.116B 12.46
LENSAR (LNSR) United States $0.101B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.082B 0.00
908 Devices (MASS) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
WORK Medical Technology Group (WOK) China $0.070B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Covalon Technologies (CVALF) Canada $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Spectral AI (MDAI) United States $0.051B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Neuronetics (STIM) United States $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.042B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
NexGel (NXGL) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.019B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00